August 7, 2026

Siti Muinah

Breakthrough Research Offers Hope for Breast Cancer Prevention, Targeting Metabolic Health in High-Risk Women breakthrough-research-offers-hope-for-breast-cancer-prevention-targeting-metabolic-health-in-high-risk-women

Breakthrough Research Offers Hope for Breast Cancer Prevention, Targeting Metabolic Health in High-Risk Women

Siti Muinah June 3, 2026 0
ANN ARBOR, MI – A significant portion of women in the United States, approximately 25% of those...
Read More Read more about Breakthrough Research Offers Hope for Breast Cancer Prevention, Targeting Metabolic Health in High-Risk Women
Rezolute’s Ersodetug Shows Significant Promise in Tumour Hyperinsulinism Trial, Boosting Stock and Offering New Hope rezolutes-ersodetug-shows-significant-promise-in-tumour-hyperinsulinism-trial-boosting-stock-and-offering-new-hope

Rezolute’s Ersodetug Shows Significant Promise in Tumour Hyperinsulinism Trial, Boosting Stock and Offering New Hope

Siti Muinah June 3, 2026 0
Boston, MA – June 5, 2026 – Rezolute, Inc. (NASDAQ: RZLT), a biopharmaceutical company focused on developing...
Read More Read more about Rezolute’s Ersodetug Shows Significant Promise in Tumour Hyperinsulinism Trial, Boosting Stock and Offering New Hope
A New Dawn in Breast Cancer Treatment: Cambridge Researchers Achieve 100% Survival in Aggressive Inherited Cancers a-new-dawn-in-breast-cancer-treatment-cambridge-researchers-achieve-100-survival-in-aggressive-inherited-cancers

A New Dawn in Breast Cancer Treatment: Cambridge Researchers Achieve 100% Survival in Aggressive Inherited Cancers

Siti Muinah June 2, 2026 0
CAMBRIDGE, UK – In a landmark medical breakthrough poised to redefine the treatment landscape for aggressive, inherited...
Read More Read more about A New Dawn in Breast Cancer Treatment: Cambridge Researchers Achieve 100% Survival in Aggressive Inherited Cancers
Incyte’s Monjuvi Shows Promising Efficacy in First-Line Diffuse Large B-cell Lymphoma, Sparking Debate on Toxicity and Treatment Regimens incytes-monjuvi-shows-promising-efficacy-in-first-line-diffuse-large-b-cell-lymphoma-sparking-debate-on-toxicity-and-treatment-regimens

Incyte’s Monjuvi Shows Promising Efficacy in First-Line Diffuse Large B-cell Lymphoma, Sparking Debate on Toxicity and Treatment Regimens

Siti Muinah June 2, 2026 0
Philadelphia, PA – [Insert Date] – In a significant development for the treatment of diffuse large B-cell...
Read More Read more about Incyte’s Monjuvi Shows Promising Efficacy in First-Line Diffuse Large B-cell Lymphoma, Sparking Debate on Toxicity and Treatment Regimens
Precision Oncology at the Forefront: ASCO 2026 Highlights Genomic Testing and Multi-Cancer Early Detection precision-oncology-at-the-forefront-asco-2026-highlights-genomic-testing-and-multi-cancer-early-detection

Precision Oncology at the Forefront: ASCO 2026 Highlights Genomic Testing and Multi-Cancer Early Detection

Siti Muinah June 1, 2026 0
The landscape of oncology is undergoing a seismic shift as precision medicine moves from a theoretical framework...
Read More Read more about Precision Oncology at the Forefront: ASCO 2026 Highlights Genomic Testing and Multi-Cancer Early Detection

You may have missed

insuring-the-psychedelic-frontier-navigating-the-liability-landscape-of-fda-approved-psilocybin

Insuring the Psychedelic Frontier: Navigating the Liability Landscape of FDA-Approved Psilocybin

Sagoh August 7, 2026
the-great-dismantling-the-transformation-of-u-s-global-health-policy-in-the-second-trump-administration

The Great Dismantling: The Transformation of U.S. Global Health Policy in the Second Trump Administration

Muslim August 7, 2026
beyond-the-cream-how-a-fathers-quest-for-relief-sparked-a-skincare-revolution

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Muslim August 7, 2026
breakthrough-in-prostate-cancer-treatment-dual-drug-therapy-significantly-slows-disease-progression-in-men-with-genetic-mutations

Breakthrough in Prostate Cancer Treatment: Dual-Drug Therapy Significantly Slows Disease Progression in Men with Genetic Mutations

Basiran August 7, 2026